UNSPSC 51284008: Guamecycline

This classification denotes a tetracycline antibiotic with the molecular formula C29H38N8O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 4NQR4R6G3S chemically known as n-((4-(amidinoamidino)-1-piperazinyl)methyl)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as guamecycline, which bears US NIH Compound Identifier 5464311.

UNSPSC 51284008 Guamecycline (Commodity) does not align with the state and local contract opportunities recently tagged under this code. The recent solicitations involve naloxone and drug deactivation systems (Seminole County, Florida), therapeutic pharmacy initiatives and direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for fire rescue operations (City of Tampa), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these opportunities concern guamecycline, an antibiotic, nor do they reflect pharmaceutical manufacturing or supply of a single branded or generic drug product. The code shows little relevant recent activity in state and local procurement markets.

The mismatch between the code's nominal scope and actual recent opportunities suggests either tagging inconsistency in the source data or a code that does not meaningfully capture current state and local demand. Firms evaluating pursuit under this Commodity code should verify the accuracy of the code assignment in any RFP, RFQ, IFB, or ITB notice before committing resources to bid preparation, as the recent posting pattern does not support a reliable profile of actual buying activity or issuing-body composition.